Chubb Limited is one of the world's largest publicly traded property and casualty (P&C) insurers, writing commercial and personal lines as well as accident and health coverage across more than 50 countries. Despite its Swiss corporate domicile, the stock trades on the New York Stock Exchange under the CB ticker and carries a market capitalization well above $130 billion. The company is also a top holding in Berkshire Hathaway's (BRK.B) equity portfolio, a signal that long-term value investors regard it as a high-quality compounder.
Investors searching for a "Chubb stock price target" have good reason to fixate on $400. Citizens raised its target to $400 in July 2026 while maintaining an Outperform rating, and independent research pieces have also cited $400 as a multi-year objective. The level sits comfortably inside the broader analyst range — which extends from roughly $270 to $425 — making it a credible, widely discussed milestone rather than an arbitrary round number.
From around $340, reaching $400 implies upside of about 17%, a meaningful but not extreme move for a large-cap insurer over a 12- to 24-month horizon. It also aligns with the psychological appeal of a clean, round figure that is often used as a reference point in both options markets and retail discussion.
The stock has traded in a 52-week range between roughly $265 and $365, meaning it is currently well above its low but still below its recent peak. That places the first meaningful resistance level at the $361–$365 zone, which represents prior highs. A decisive break above that area would open the path toward $400, with little established supply overhead in between. On the downside, the mid-$320s has acted as a support level during recent pullbacks.
The longer-term trend structure remains constructive: the shares have advanced roughly 17% over the past year, outpacing the broader insurance industry. Sustaining that momentum through the prior high is the clearest technical requirement for a move toward $400.
Several fundamental tailwinds support the bullish case. Chubb has beaten earnings expectations in four consecutive quarters by a meaningful margin, driven by premium growth and firm pricing in commercial and specialty lines. Its investment portfolio also benefits from an extended period of elevated interest rates, which boosts investment income — a key profit source for insurers that hold large fixed-income portfolios.
Capital returns add another catalyst. The company raised its quarterly dividend to $1.02 per share, and management has signaled a willingness to return the bulk of operating earnings to shareholders through dividends and buybacks. A core return on equity (ROE) in the mid-teens underpins the idea that the stock deserves a higher multiple over time.
The path to $400 is not without obstacles. Analysts have flagged softening pricing in certain property lines and persistent casualty loss-cost inflation, which could pressure reserve adequacy and underwriting margins. Elevated catastrophe losses in any given quarter can also create short-term volatility in results.
Valuation is a secondary concern. The stock trades at a price-to-earnings (P/E) ratio of roughly 11 to 12 times forward earnings — inexpensive versus the broad market, but not necessarily cheap relative to its own history after a strong run. With the shares already near 52-week highs, some analysts have moved to Hold ratings, arguing that near-term upside is already largely reflected in the price.
The analyst consensus remains positive, with a "Buy" rating and an average price target near $366, roughly 7% above recent levels. Bullish outliers include Argus Research at $396, Citi at $395, and Citizens at $400, while Keefe, Bruyette & Woods has been near $373–$389. On the other side, more cautious voices at Morgan Stanley, Mizuho, and Wells Fargo hold targets in the $340–$360 range.
Importantly, reaching $400 would require only about 14 times this year's expected earnings per share (EPS) of roughly $28, and less than that on forward estimates near $29. That is a reasonable multiple for a blue-chip insurer, suggesting the target is not dependent on excessive optimism — but it does assume earnings growth continues on its current trajectory.
Traders monitoring whether CB can build the momentum needed to approach $400 may benefit from automated tools like Tickeron's AI Daily Buy/Sell Signals. This product uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to spot emerging opportunities, track existing positions, and identify shifting trends more efficiently than manual screening alone. For investors watching the insurance sector closely, adding an AI-powered signal layer can help clarify when a breakout toward the next resistance level is actually gaining confirmation.
A move to $400 for Chubb appears plausible but is far from guaranteed. The strongest arguments in its favor are a resilient earnings track record, favorable investment income, disciplined capital returns, and a consensus analyst view that still implies upside. The primary risks are softening pricing in certain segments, casualty reserve inflation, and the stock's proximity to recent highs, which leaves it vulnerable to profit-taking.
The key milestone to watch is whether CB can clear and hold above the $361–$365 resistance zone. A confirmed breakout there, supported by continued earnings beats, would materially improve the odds of reaching $400. Without it, the stock may remain rangebound as investors wait for clearer signals on pricing and reserve trends.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, CB has been closely correlated with HIG. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if CB jumps, then HIG could also see price increases.